Phospholipids in Pharmaceutical - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2754719
- Published On: Oct, 2023
- Category : Chemicals & Materials
- Pages : 131
-
According to Research, the global market for Phospholipids in Pharmaceutical should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Phospholipids in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Phospholipids in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Oral Products grew percent to account for percent of the total market sales, and Dermal Products grew percent.
In pharmaceutical formulations, phospholipids obtained from plant or animal sources and synthetic phospholipids are used. Natural phospholipids are purified from, e.g., soybeans or egg yolk using non-toxic solvent extraction and chromatographic procedures with low consumption of energy and minimum possible waste. Because of the use of validated purification procedures and sourcing of raw materials with consistent quality, the resulting products differing in phosphatidylcholine content possess an excellent batch to batch reproducibility with respect to phospholipid and fatty acid composition. The natural phospholipids are described in pharmacopeias and relevant regulatory guidance documentation of the Food and Drug Administration (FDA) and European Medicines Agency (EMA). Synthetic phospholipids with specific polar head group, fatty acid composition can be manufactured using various synthesis routes. Synthetic phospholipids with the natural stereochemical configuration are preferably synthesized from glycerophosphocholine (GPC), which is obtained from natural phospholipids, using acylation and enzyme catalyzed reactions. Synthetic phospholipids play compared to natural phospholipid (including hydrogenated phospholipids), as derived from the number of drug products containing synthetic phospholipids, a minor role. Only in a few pharmaceutical products synthetic phospholipids are used. Natural phospholipids are used in oral, dermal, and parenteral products including liposomes. Natural phospholipids instead of synthetic phospholipids should be selected as phospholipid excipients for formulation development, whenever possible, because natural phospholipids are derived from renewable sources and produced with more ecologically friendly processes and are available in larger scale at relatively low costs compared to synthetic phospholipids.
This report studies and analyses global Phospholipids in Pharmaceutical status and future trends, helps the client to determine the Phospholipids in Pharmaceutical market size of the total market opportunity by Source, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Phospholipids in Pharmaceutical, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Phospholipids in Pharmaceutical market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Phospholipids in Pharmaceutical sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Phospholipids in Pharmaceutical sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Phospholipids in Pharmaceutical key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Phospholipids in Pharmaceutical key producing regions, capacity, production, and year over year growth
(6) Phospholipids in Pharmaceutical industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Cargill
Avril
Croda
Lipoid
Nippon Fine Chemical
Sonic Biochem
Nabros Pharma
Vav
NOF
Market segment by Source, covers
Soy
Egg
Synthetic
Others
Market segment by Application, can be divided into
Oral Products
Dermal Products
Parenteral Products
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Phospholipids in Pharmaceutical product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Phospholipids in Pharmaceutical market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Phospholipids in Pharmaceutical market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Phospholipids in Pharmaceutical, percent & CAGR, 2018-2029
Chapter 5: Phospholipids in Pharmaceutical industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
-
With tables and figures helping analyze worldwide Phospholipids in Pharmaceutical Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Phospholipids in Pharmaceutical Definition
1.2 Global Phospholipids in Pharmaceutical Market Size and Forecast
1.2.1 By Consumption Value, Global Phospholipids in Pharmaceutical Market Size，2018-2029
1.2.2 By Sales Quantity, Global Phospholipids in Pharmaceutical Market Size，2018-2029
1.2.3 Global Phospholipids in Pharmaceutical Average Selling Price (ASP)，2018-20291.3 China Phospholipids in Pharmaceutical Market Size and Forecast
1.3.1 By Consumption Value, China Phospholipids in Pharmaceutical Market Size，2018-2029
1.3.2 By Sales Quantity, China Phospholipids in Pharmaceutical Market Size，2018-2029
1.3.3 China Phospholipids in Pharmaceutical Average Selling Price (ASP)， 2018-20291.4 Share of China Phospholipids in Pharmaceutical Market with Respect to the Global Market
1.4.1 By Consumption Value, China Phospholipids in Pharmaceutical Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Phospholipids in Pharmaceutical Market Share in Global, 2018-2029
1.4.3 Phospholipids in Pharmaceutical Market Size: China VS Global, 2018-20291.5 Phospholipids in Pharmaceutical Market Dynamics
1.5.1 Phospholipids in Pharmaceutical Market Drivers
1.5.2 Phospholipids in Pharmaceutical Market Restraints
1.5.3 Phospholipids in Pharmaceutical Industry Trends
1.5.4 Phospholipids in Pharmaceutical Industry Policy
2 Global Leading Manufacturers and Market Share2.1 By Revenue of Phospholipids in Pharmaceutical, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Phospholipids in Pharmaceutical, Global Market Share by Company, 2018-2023
2.3 Phospholipids in Pharmaceutical Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Phospholipids in Pharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Phospholipids in Pharmaceutical Concentration Ratio
2.6 Global Phospholipids in Pharmaceutical Mergers & Acquisitions, Expansion Plans
2.7 Global Phospholipids in Pharmaceutical Manufacturers Product Type
2.8 Head Office and Phospholipids in Pharmaceutical Production Site of Key Manufacturer
2.9 Phospholipids in Pharmaceutical Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share3.1 By Revenue of Phospholipids in Pharmaceutical, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Phospholipids in Pharmaceutical, China Market Share by Company, 2018-2023
3.3 China Phospholipids in Pharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions4.1 Global Phospholipids in Pharmaceutical Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Phospholipids in Pharmaceutical Capacity by Region
4.3 Global Phospholipids in Pharmaceutical Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Phospholipids in Pharmaceutical Production by Region, 2018-2029
4.5 Global Phospholipids in Pharmaceutical Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis5.1 Phospholipids in Pharmaceutical Industry Chain
5.2 Phospholipids in Pharmaceutical Upstream Analysis
5.2.1 Phospholipids in Pharmaceutical Core Raw Materials
5.2.2 Main Manufacturers of Phospholipids in Pharmaceutical Core Raw Materials5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Phospholipids in Pharmaceutical Production Mode
5.6 Phospholipids in Pharmaceutical Procurement Model
5.7 Phospholipids in Pharmaceutical Industry Sales Model and Sales Channels
5.7.1 Phospholipids in Pharmaceutical Sales Model
5.7.2 Phospholipids in Pharmaceutical Typical Distributors
6 Sights by Source6.1 Phospholipids in Pharmaceutical Classification
6.1.1 Soy
6.1.2 Egg
6.1.3 Synthetic
6.1.4 Others6.2 By Source, Global Phospholipids in Pharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Source, Global Phospholipids in Pharmaceutical Consumption Value, 2018-2029
6.4 By Source, Global Phospholipids in Pharmaceutical Sales Quantity, 2018-2029
6.5 By Source, Global Phospholipids in Pharmaceutical Average Selling Price (ASP), 2018-2029
7 Sights by Application7.1 Phospholipids in Pharmaceutical Segment by Application
7.1.1 Oral Products
7.1.2 Dermal Products
7.1.3 Parenteral Products
7.1.4 Others7.2 By Application, Global Phospholipids in Pharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Phospholipids in Pharmaceutical Consumption Value, 2018-2029
7.4 By Application, Global Phospholipids in Pharmaceutical Sales Quantity, 2018-2029
7.5 By Application, Global Phospholipids in Pharmaceutical Price, 2018-2029
8 Sales Sights by Region8.1 By Region, Global Phospholipids in Pharmaceutical Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Phospholipids in Pharmaceutical Consumption Value, 2018-2029
8.3 By Region, Global Phospholipids in Pharmaceutical Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Phospholipids in Pharmaceutical & Forecasts, 2018-2029
8.4.2 By Country, North America Phospholipids in Pharmaceutical Market Size Market Share8.5 Europe
8.5.1 Europe Phospholipids in Pharmaceutical Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Phospholipids in Pharmaceutical Market Size Market Share8.6 Asia Pacific
8.6.1 Asia Pacific Phospholipids in Pharmaceutical Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Phospholipids in Pharmaceutical Market Size Market Share
8.7 South America
8.7.1 South America Phospholipids in Pharmaceutical Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Phospholipids in Pharmaceutical Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level9.1 By Country, Global Phospholipids in Pharmaceutical Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Phospholipids in Pharmaceutical Consumption Value, 2018-2029
9.3 By Country, Global Phospholipids in Pharmaceutical Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Phospholipids in Pharmaceutical Market Size, 2018-2029
9.4.2 By Source, U.S. Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 20299.5 Europe
9.5.1 Europe Phospholipids in Pharmaceutical Market Size, 2018-2029
9.5.2 By Source, Europe Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 20299.6 China
9.6.1 China Phospholipids in Pharmaceutical Market Size, 2018-2029
9.6.2 By Source, China Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Phospholipids in Pharmaceutical Market Size, 2018-2029
9.7.2 By Source, Japan Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Phospholipids in Pharmaceutical Market Size, 2018-2029
9.8.2 By Source, South Korea Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Phospholipids in Pharmaceutical Market Size, 2018-2029
9.9.2 By Source, Southeast Asia Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 20299.10 India
9.10.1 India Phospholipids in Pharmaceutical Market Size, 2018-2029
9.10.2 By Source, India Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Phospholipids in Pharmaceutical Market Size, 2018-2029
9.11.2 By Source, Middle East & Africa Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Phospholipids in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile10.1 Cargill
10.1.1 Cargill Company Information, Head Office, Market Area, and Industry Position
10.1.2 Cargill Phospholipids in Pharmaceutical Models, Specifications, and Application
10.1.3 Cargill Phospholipids in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Cargill Company Profile and Main Business
10.1.5 Cargill Recent Developments10.2 Avril
10.2.1 Avril Company Information, Head Office, Market Area, and Industry Position
10.2.2 Avril Phospholipids in Pharmaceutical Models, Specifications, and Application
10.2.3 Avril Phospholipids in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Avril Company Profile and Main Business
10.2.5 Avril Recent Developments10.3 Croda
10.3.1 Croda Company Information, Head Office, Market Area, and Industry Position
10.3.2 Croda Phospholipids in Pharmaceutical Models, Specifications, and Application
10.3.3 Croda Phospholipids in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Croda Company Profile and Main Business
10.3.5 Croda Recent Developments10.4 Lipoid
10.4.1 Lipoid Company Information, Head Office, Market Area, and Industry Position
10.4.2 Lipoid Phospholipids in Pharmaceutical Models, Specifications, and Application
10.4.3 Lipoid Phospholipids in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Lipoid Company Profile and Main Business
10.4.5 Lipoid Recent Developments10.5 Nippon Fine Chemical
10.5.1 Nippon Fine Chemical Company Information, Head Office, Market Area, and Industry Position
10.5.2 Nippon Fine Chemical Phospholipids in Pharmaceutical Models, Specifications, and Application
10.5.3 Nippon Fine Chemical Phospholipids in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Nippon Fine Chemical Company Profile and Main Business
10.5.5 Nippon Fine Chemical Recent Developments10.6 Sonic Biochem
10.6.1 Sonic Biochem Company Information, Head Office, Market Area, and Industry Position
10.6.2 Sonic Biochem Phospholipids in Pharmaceutical Models, Specifications, and Application
10.6.3 Sonic Biochem Phospholipids in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sonic Biochem Company Profile and Main Business
10.6.5 Sonic Biochem Recent Developments
10.7 Nabros Pharma
10.7.1 Nabros Pharma Company Information, Head Office, Market Area, and Industry Position
10.7.2 Nabros Pharma Phospholipids in Pharmaceutical Models, Specifications, and Application
10.7.3 Nabros Pharma Phospholipids in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Nabros Pharma Company Profile and Main Business
10.7.5 Nabros Pharma Recent Developments
10.8 Vav
10.8.1 Vav Company Information, Head Office, Market Area, and Industry Position
10.8.2 Vav Phospholipids in Pharmaceutical Models, Specifications, and Application
10.8.3 Vav Phospholipids in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Vav Company Profile and Main Business
10.8.5 Vav Recent Developments
10.9 NOF
10.9.1 NOF Company Information, Head Office, Market Area, and Industry Position
10.9.2 NOF Phospholipids in Pharmaceutical Models, Specifications, and Application
10.9.3 NOF Phospholipids in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 NOF Company Profile and Main Business
10.9.5 NOF Recent Developments
11 Conclusion
12 Appendix12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources12.3 Market Estimation Model
12.4 Disclaimer
-
The Phospholipids in Pharmaceutical Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Phospholipids in Pharmaceutical Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
From 2025 to 2030, the Phospholipids in Pharmaceutical Global and China Top Players Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
The influx of capital into the Phospholipids in Pharmaceutical Global and China Top Players Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
In this highly competitive and rapidly evolving Phospholipids in Pharmaceutical Global and China Top Players Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
